Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 4 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
miR-101-5p modulation of CD47 in diffuse large B-cell lymphoma: Implications for anti-CD47 immunotherapy and prognostication.
Br J Haematol. 2024 Feb;204(2):730-734. doi: 10.1111/bjh.19264. Epub 2023 Dec 12.
Br J Haematol. 2024.
PMID: 38087456
No abstract available.
Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases.
Antony IR, Wong BHS, Kelleher D, Verma NK.
Antony IR, et al.
Cells. 2023 Oct 29;12(21):2541. doi: 10.3390/cells12212541.
Cells. 2023.
PMID: 37947619
Free PMC article.
Review.
Item in Clipboard
Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
Thng DKH, Hooi L, Toh CCM, Lim JJ, Rajagopalan D, Syariff IQC, Tan ZM, Rashid MBMA, Zhou L, Kow AWC, Bonney GK, Goh BKP, Kam JH, Jha S, Dan YY, Chow PKH, Toh TB, Chow EK.
Thng DKH, et al.
Mol Oncol. 2023 Nov;17(11):2275-2294. doi: 10.1002/1878-0261.13417. Epub 2023 Mar 29.
Mol Oncol. 2023.
PMID: 36896891
Free PMC article.
Item in Clipboard
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.
Tan GF, Goh S, Chang EWY, Tan YH, Chiang J, Yang VS, Poon EYL, Somasundaram N, Bin Harunal Rashid MF, Tao M, Lim ST, Ong CK, Chan JY.
Tan GF, et al.
Hematol Rep. 2023 Feb 10;15(1):108-118. doi: 10.3390/hematolrep15010012.
Hematol Rep. 2023.
PMID: 36810555
Free PMC article.
Item in Clipboard
IRF4 as an Oncogenic Master Transcription Factor.
Wong RWJ, Ong JZL, Theardy MS, Sanda T.
Wong RWJ, et al.
Cancers (Basel). 2022 Sep 2;14(17):4314. doi: 10.3390/cancers14174314.
Cancers (Basel). 2022.
PMID: 36077849
Free PMC article.
Review.
Item in Clipboard
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors.
Lim JJ, Hooi L, Dan YY, Bonney GK, Zhou L, Chow PK, Chee CE, Toh TB, Chow EK.
Lim JJ, et al.
J Exp Clin Cancer Res. 2022 Aug 15;41(1):249. doi: 10.1186/s13046-022-02436-9.
J Exp Clin Cancer Res. 2022.
PMID: 35971164
Free PMC article.
Item in Clipboard
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Kizhakeyil A, Zaini NBM, Poh ZS, Wong BHS, Loh X, Ng AS, Low ZS, Prasannan P, Gong C, Tan MGK, Nagarajan C, Huang D, Lu PW, Lim JQ, Barrans S, Ong CK, Lim ST, Chng WJ, Follows G, Hodson DJ, Du MQ, Goh YT, Tan SH, Grigoropoulos NF, Verma NK.
Kizhakeyil A, et al.
Mol Cancer. 2021 Oct 16;20(1):134. doi: 10.1186/s12943-021-01437-0.
Mol Cancer. 2021.
PMID: 34654425
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite